Engineers Gate Manager’s Dianthus Therapeutics DNTH Stock Holding History

Engineers Gate Manager’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Sell	11,580 -10,330	-47%	-$902K	0.01%	1015
2026 Q1	$1.84M	Sell	21,910 -1,470	-6%	-$85.1K	0.02%	749
2025 Q4	$963K	Buy	23,380 +3,001	+15%	+$116K	0.01%	1059
2025 Q3	$802K	Buy	+20,379	New	+$521K	0.01%	1272
2024 Q2	–	Sell	-7,786	Closed	-$234K	–	1995
2024 Q1	$234K	Buy	+7,786	New	+$169K	0.01%	1589
2023 Q1	–	Sell	-2,131	Closed	-$13.5K	–	1735
2022 Q4	$13.5K	Buy	+2,131	New	+$37.7K	﹤0.01%	1624
2022 Q1	–	Sell	-948	Closed	-$67K	–	1951
2021 Q4	$67K	Buy	948 +317	+50%	+$31.9K	﹤0.01%	1840
2021 Q3	$74K	Buy	+631	New	+$73.5K	﹤0.01%	1559
2020 Q4	–	Sell	-756	Closed	-$82K	–	1758
2020 Q3	$82K	Buy	+756	New	+$89.6K	﹤0.01%	1580

Other funds holding DNTH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Engineers Gate Manager's DNTH Position: Q2 2026 in Review

Engineers Gate Manager reduced its Dianthus Therapeutics (DNTH) stake by 47% in Q2 2026, selling an estimated $902K and leaving 11,580 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #1015.

Engineers Gate Manager first reported a position in DNTH in Q3 2020 and has held it in 9 quarters since. The position peaked at $1.84M in Q1 2026. 270 funds tracked by Wall St. Rank hold DNTH as of Q2 2026.

Engineers Gate Manager held 11,580 shares of Dianthus Therapeutics worth $1.13M as of Q2 2026.
Engineers Gate Manager sold 10,330 Dianthus Therapeutics shares in Q2 2026, an estimated $902K.
Dianthus Therapeutics made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1015 holding.
Engineers Gate Manager first reported a position in Dianthus Therapeutics in Q3 2020 and has held it in 9 quarters since.
Engineers Gate Manager's Dianthus Therapeutics position peaked at $1.84M in Q1 2026.
270 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.